958.62MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00972D1054
CUSIP
00972D105
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.09
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.21
Wall Street Target Price
7.40
EPS Estimate Current Year
-0.06
EPS Estimate Next Year
0.27
EPS Estimate Current Quarter
-0.04
EPS Estimate Next Quarter
-0.05
Most Recent Quarter
-
Revenue TTM
184,908,992
Gross Profit TTM
153,314,000
EBITDA
10,202,000
Profit Margin
-24.51%
Return On Assets TTM
-4.26%
Return On Equity TTM
-553.45%
Revenue Per Share TTM
0.846
Qtly Revenue Growth YOY
75.80%
Diluted Eps TTM
-0.21
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
5.1914
Price Book MRQ
38.7848
Enterprise Value Revenue
4
Enterprise Value EBITDA
135
159.19
2.12%10.50
1.40%131.25
1.16%15.52
0.42%51.98
0.00%18.05
0.00%28.35
0.00%25.94
-1.48%16.64
-0.68%142.40
-0.53%